Karriereverlauf von Mark Hernon
Ehemalige bekannte Positionen von Mark Hernon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RUBIUS THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01.09.2021 | 01.09.2022 |
BIOGEN INC. | Chief Tech/Sci/R&D Officer | 04.12.2017 | 01.03.2021 |
Ausbildung von Mark Hernon
Rensselaer Polytechnic Institute | Graduate Degree |
The Lally School of Management & Technology | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOGEN INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Börse
- Insiders
- Mark Hernon
- Erfahrung